Shares of Arteris, Inc. (NASDAQ:AIP - Get Free Report) gapped up before the market opened on Monday . The stock had previously closed at $10.98, but opened at $12.81. Arteris shares last traded at $14.31, with a volume of 2,102,968 shares trading hands.
Wall Street Analysts Forecast Growth
A number of equities analysts have weighed in on AIP shares. Wall Street Zen raised shares of Arteris from a "sell" rating to a "hold" rating in a research note on Monday, September 15th. TD Cowen boosted their target price on shares of Arteris from $12.00 to $15.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. Finally, Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Arteris in a research note on Saturday, September 27th. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, Arteris currently has an average rating of "Moderate Buy" and a consensus price target of $15.00.
View Our Latest Stock Report on AIP
Arteris Stock Performance
The firm's 50-day moving average price is $9.65 and its 200 day moving average price is $8.43. The company has a market cap of $585.46 million, a price-to-earnings ratio of -16.74 and a beta of 1.45.
Arteris (NASDAQ:AIP - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported ($0.11) EPS for the quarter, hitting the consensus estimate of ($0.11). Arteris had a negative net margin of 52.41% and a negative return on equity of 8,546.17%. The company had revenue of $16.50 million during the quarter, compared to analysts' expectations of $16.35 million. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, equities research analysts predict that Arteris, Inc. will post -0.73 EPS for the current fiscal year.
Insider Buying and Selling at Arteris
In related news, COO Laurent R. Moll sold 8,129 shares of the business's stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $8.74, for a total transaction of $71,047.46. Following the completion of the transaction, the chief operating officer owned 386,552 shares in the company, valued at approximately $3,378,464.48. The trade was a 2.06% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Paul L. Alpern sold 5,000 shares of the business's stock in a transaction that occurred on Wednesday, October 1st. The shares were sold at an average price of $10.31, for a total transaction of $51,550.00. Following the transaction, the vice president owned 73,587 shares of the company's stock, valued at approximately $758,681.97. This represents a 6.36% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 426,762 shares of company stock worth $5,176,840 in the last 90 days. Corporate insiders own 29.10% of the company's stock.
Institutional Inflows and Outflows
A number of institutional investors have recently bought and sold shares of AIP. Bank of America Corp DE grew its holdings in Arteris by 36.9% during the fourth quarter. Bank of America Corp DE now owns 33,619 shares of the company's stock valued at $343,000 after purchasing an additional 9,068 shares during the period. Two Sigma Investments LP grew its holdings in Arteris by 166.0% during the fourth quarter. Two Sigma Investments LP now owns 60,533 shares of the company's stock valued at $617,000 after purchasing an additional 37,772 shares during the period. Squarepoint Ops LLC acquired a new position in Arteris during the fourth quarter valued at approximately $160,000. GAMMA Investing LLC grew its holdings in Arteris by 11,823.3% during the first quarter. GAMMA Investing LLC now owns 5,127 shares of the company's stock valued at $350,000 after purchasing an additional 5,084 shares during the period. Finally, Cambridge Investment Research Advisors Inc. acquired a new position in Arteris during the first quarter valued at approximately $95,000. Institutional investors and hedge funds own 64.36% of the company's stock.
About Arteris
(
Get Free Report)
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.